Figure 2. Efficacy results.
(A) Estimated linear dose response for the intent-to-treat population using the MCP-Mod procedure with 80% point-wise confidence interval (CI). (B) Mean change from baseline in average pain intensity score to 4, 8, and 12 weeks in the double-blind efficacy phase (intent-to-treat population). Locf = last observation carried forward.